Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors
Public ClinicalTrials.gov record NCT02709889. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Study of Rovalpituzumab Tesirine in Subjects With Delta-Like Protein 3-Expressing Advanced Solid Tumors
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to assess the safety and tolerability of rovalpituzumab tesirine in subjects with specific delta-like protein 3-expressing advanced solid tumors.
Study identification
- NCT ID
- NCT02709889
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 23, 2016 (Actual)
- Primary completion
- Aug 27, 2019 (Actual)
- Completion
- Aug 27, 2019 (Actual)
- Last update posted
- Oct 19, 2020
2016 – 2019
United States locations
- U.S. sites
- 30
- U.S. states
- 21
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner MD Anderson Cancer Ctr /ID# 155424 | Gilbert | Arizona | 85234 | — |
| Mayo Clinic - Scottsdale /ID# 155419 | Scottsdale | Arizona | 85259 | — |
| University of California, Los Angeles /ID# 155429 | Los Angeles | California | 90095 | — |
| Univ California, San Francisco /ID# 155409 | San Francisco | California | 94143-2204 | — |
| Cedars-Sinai Medical Center - West Hollywood /ID# 155428 | West Hollywood | California | 90048 | — |
| Univ of Colorado Cancer Center /ID# 155415 | Aurora | Colorado | 80045 | — |
| Sarah Cannon Research Institute at HealthONE - Denver /ID# 155420 | Denver | Colorado | 80218 | — |
| University of Florida - Archer /ID# 155414 | Gainesville | Florida | 32610 | — |
| Moffitt Cancer Center /ID# 170220 | Tampa | Florida | 33612-9416 | — |
| Emory University Hospital /ID# 155417 | Atlanta | Georgia | 30322 | — |
| University of Kentucky Chandler Medical Center /ID# 155423 | Lexington | Kentucky | 40536 | — |
| Johns Hopkins University /ID# 155412 | Baltimore | Maryland | 21287 | — |
| Massachusetts General Hospital /ID# 155411 | Boston | Massachusetts | 02114 | — |
| Dana-Farber Cancer Institute /ID# 171044 | Boston | Massachusetts | 02215 | — |
| Mayo Clinic - Rochester /ID# 155416 | Rochester | Minnesota | 55905-0001 | — |
| Washington University-School of Medicine /ID# 155425 | St Louis | Missouri | 63110 | — |
| Rutgers Cancer Institute of NJ /ID# 162010 | New Brunswick | New Jersey | 08903 | — |
| University of New Mexico /ID# 205054 | Albuquerque | New Mexico | 87102 | — |
| Roswell Park Comprehensive Cancer Center /ID# 162015 | Buffalo | New York | 14263 | — |
| Weill Cornell Medical College /ID# 155418 | New York | New York | 10021 | — |
| Duke University Medical Center /ID# 155421 | Durham | North Carolina | 27710-3000 | — |
| Univ Hosp Cleveland /ID# 155410 | Cleveland | Ohio | 44106 | — |
| Oregon Health and Science University /ID# 162011 | Portland | Oregon | 97239 | — |
| Greenville Hospital System /ID# 155427 | Greenville | South Carolina | 29605 | — |
| Mary Crowley Cancer Research /ID# 162014 | Dallas | Texas | 75230 | — |
| Texas Oncology - Forth Worth /ID# 162045 | Fort Worth | Texas | 76104-2150 | — |
| University of Texas MD Anderson Cancer Center /ID# 155413 | Houston | Texas | 77030 | — |
| University of Utah /ID# 155426 | Salt Lake City | Utah | 84112-5500 | — |
| Virginia Cancer Specialists /ID# 162006 | Fairfax | Virginia | 22031 | — |
| Northwest Cancer Specialists, P.C. /ID# 155431 | Vancouver | Washington | 98684 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02709889, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 19, 2020 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02709889 live on ClinicalTrials.gov.